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Background
It has been suggested that the stability of the CD4 cell
reservoir could be related to the continuous replenish-
ment from plasma-residual HIV-1. Intensification with
an entry inhibitor could help eliminate the detectable
levels of ongoing viral replication and accelerate the
d e c a yo ft h er e s e r v o i rb yi n h i b i t i n gt h ee n t r yo ft h e
virus into the cells.
Methods
The intensification study with an entry inhibitor (mara-
viroc-MVC) included patients with stable antiretroviral
therapy (ART) with three or more drugs, viral load (VL)
of <50 copies/ml for two or more years, CD4 count of
>350 cells/mm
3 and CCR5-tropism. Latently infected
resting CD4 cells were determined at baseline, week 12
and week 24, with further analyses planned at week 36
and week 48. Highly purified resting CD4 cells were iso-
lated using magnetic beads rendering ~20 million and
plated in replicate dilutions and stimulated in a limiting
dilution culture assay, with irradiated PBMCs from a
seronegative donor. Cells containing HIV-replication-
competent were quantified by HIV-1 p24 Antigen Assay
(results in infective units per million).
Results
Nine patients have been included. Median time of HIV-
1 diagnosis was 103 months [IQR 58-240], ART was
administered for a median of 75 months [IQR 38-144],
and the median baseline CD4 count was 711 cells/mm
3
[IQR 547-793]. At baseline, the reservoir could be quan-
tified in six out of nine patients. One patient has left the
study, and the other eight patients continue with VL of
<50 copies/ml and median CD4 count of 680 cells/mm
3
[IQR 601-910]. After 24 weeks of intensification with
MVC, when compared with baseline, a persistent
decrease in the latent reservoir has been observed in
three patients, no change (always undetectable) in two
patients, and an increase, after an initial decrease, in the
remaining three patients.
Conclusions
Intensification with MVC seems to have a uniform, sig-
nificant initial impact (measured at 12 weeks) on the
HIV-1 latent reservoir that continues to be observed in
most patients after 24 weeks.
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